Literature DB >> 12202289

Ziprasidone alternative for olanzapine-induced hyperglycemia.

Baruch Spivak, Sayed S Alamy, L Fredrik Jarskog, Brian B Sheitman, Jeffrey A Lieberman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12202289     DOI： 10.1176/appi.ajp.159.9.1606

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  4 in total

1.  Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.

Authors:  David C Henderson; Xiaoduo Fan; Paul M Copeland; Bikash Sharma; Christina P Borba; Sharon I Forstbauer; Kate Miley; Ryan Boxill; Oliver Freudenreich; Corrine Cather; Anne E Evins; Donald C Goff
Journal:  Hum Psychopharmacol       Date:  2009-04       Impact factor: 1.672

Review 2.  Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.

Authors:  Kristina Melkersson; Marja-Liisa Dahl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Hyperglycemia associated with olanzapine treatment.

Authors:  P N Suresh Kumar; Biju Thomas
Journal:  Indian J Psychiatry       Date:  2011-04       Impact factor: 1.759

4.  A case report and literature review of olanzapine-associated hyperglycemia with previous history of gestational diabetes.

Authors:  Jennifer N Alastanos; Devika Suri; Hayato DeLellis; Andrea Mapugay
Journal:  Ment Health Clin       Date:  2022-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.